CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 87 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2018. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $509,000 | +97.3% | 104,527 | 0.0% | 0.00% | – |
| Q1 2021 | $258,000 | +4200.0% | 104,527 | +1380.8% | 0.00% | – |
| Q2 2019 | $6,000 | -91.4% | 7,059 | -86.4% | 0.00% | – |
| Q1 2019 | $70,000 | -87.8% | 52,021 | -90.3% | 0.00% | – |
| Q4 2018 | $573,000 | -50.9% | 536,761 | +182.2% | 0.00% | – |
| Q3 2018 | $1,168,000 | +7.8% | 190,195 | +87.4% | 0.00% | – |
| Q2 2018 | $1,083,000 | +259.8% | 101,484 | +260.3% | 0.00% | – |
| Q1 2018 | $301,000 | -9.1% | 28,168 | -40.7% | 0.00% | – |
| Q4 2017 | $331,000 | +7.1% | 47,523 | +33.8% | 0.00% | – |
| Q3 2017 | $309,000 | -71.5% | 35,511 | -70.3% | 0.00% | -100.0% |
| Q2 2017 | $1,086,000 | +159.2% | 119,431 | +125.2% | 0.00% | – |
| Q1 2017 | $419,000 | +212.7% | 53,027 | +247.6% | 0.00% | – |
| Q4 2016 | $134,000 | -22.5% | 15,257 | +52.6% | 0.00% | – |
| Q3 2016 | $173,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |